TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
01 1TAPI Technology & API Services
02 2Fareva
03 2MYTHEN SPA
04 1Olon S.p.A
05 1Pfizer Inc
06 1Teva Pharmaceutical Industries
01 2Israel
02 3Italy
03 2Luxembourg
04 1U.S.A
01 3Active
02 3Inactive
03 2Blank
01 2Valid
02 6Blank
01 1223MF10158
02 7Blank
01 8Blank
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12241
Submission : 1996-12-02
Status : Active
Type : II
Certificate Number : R1-CEP 2000-160 - Rev 04
Issue Date : 2022-06-17
Type : Chemical
Substance Number : 896
Status : Valid
Available Reg Filing : BR, ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18459
Submission : 2005-06-27
Status : Active
Type : II
Certificate Number : CEP 2009-401 - Rev 05
Issue Date : 2024-10-25
Type : Chemical
Substance Number : 896
Status : Valid
Registration Number : 223MF10158
Registrant's Address : NUERNBERGER STRASSE 12, 90537 FEUCHT, GERMANY
Initial Date of Registration : 2011-11-14
Latest Date of Registration : --
NDC Package Code : 46014-1003
Start Marketing Date : 2005-09-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-06-25
Pay. Date : 2013-01-15
DMF Number : 25421
Submission : 2012-03-01
Status : Active
Type : II
NDC Package Code : 46014-1003
Start Marketing Date : 2005-09-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10041
Submission : 1993-01-13
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16653
Submission : 2003-06-16
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19052
Submission : 2005-12-17
Status : Inactive
Type : II
NDC Package Code : 51846-1016
Start Marketing Date : 2022-01-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0060
Start Marketing Date : 2015-01-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Deferoxamine Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deferoxamine Mesylate, including repackagers and relabelers. The FDA regulates Deferoxamine Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deferoxamine Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Deferoxamine Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Deferoxamine Mesylate supplier is an individual or a company that provides Deferoxamine Mesylate active pharmaceutical ingredient (API) or Deferoxamine Mesylate finished formulations upon request. The Deferoxamine Mesylate suppliers may include Deferoxamine Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Deferoxamine Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 6 companies offering Deferoxamine Mesylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?